slow your roll man. We only have CV19 and HIV. A
Post# of 155044
Just the past few weeks have shown how fickle investors are. We KNOW leronlimab is efficacious for CV19, yet we all (not me) hope that NP PRs efficacy with topline results.
Let's not talk as if all other potential indications are a done deal.

